grant
saveTIBA BIOTECH, LLC — Targeted Delivery of Tumor Antigen esaRNA to the Spleen for Cancer Immunotherapy
September 10, 2025updated 2mo ago
community read0 votes
CA grant. $399,300. PI: Jasdave Chahal
view source ↗CA grant. $399,300. PI: Jasdave Chahal
view source ↗
comments(0)
5-min edit window · permanent after that